FMP

FMP

Enter

PROC - Procaps Group S.A.

Financial Summary of Procaps Group S.A.(PROC), Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company f

photo-url-https://financialmodelingprep.com/image-stock/PROC.png

Procaps Group S.A.

PROC

NASDAQ

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

2.75 USD

-0.2101 (-7.64%)

About

ceo

Mr. Ruben Minski

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.procapsgroup.com

exchange

NASDAQ

Description

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin car...

CIK

0001863362

ISIN

LU2376511205

CUSIP

L7756P102

Address

9 Rue de Bitbourg

Phone

356 7995 6138

Country

LU

Employee

5,500

IPO Date

Dec 9, 2019

Summary

CIK

0001863362

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

L7756P102

ISIN

LU2376511205

Country

LU

Price

2.75

Beta

0.2

Volume Avg.

12.89k

Market Cap

310.25M

Shares

-

52-Week

1.95-4.95

DCF

8.02

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

5.39

P/B

-

Website

https://www.procapsgroup.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest PROC News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep